Please assess the completion status of the following clinical trial:

Trial Title: MK0476 Study in Adult Patients With Acute Asthma (0476-322)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Adult Patients With Acute Asthma Attacks~Exclusion Criteria:~* Patient Has Any Known Or Suspected, Acute Or Chronic Cause For Their Pulmonary Symptoms Other Than Asthma (E.G., Copd, Chronic Heart Failure, Etc.)~* Patient Has A Smoking History (20 Cigarettes Per Day) Of More Than 15 Years~* Patient Has A Disease Of The Cardiovascular, Hepatic, Renal, Hematologic Systems, Or Other Severe Disease

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Placebo
- 2 (Type: EXPERIMENTAL): MK0476 7 mg injection
- 3 (Type: EXPERIMENTAL): MK0476 14 mg injection

Based on this trial design, predict the completion outcome and termination type (if applicable).